84 related articles for article (PubMed ID: 38737068)
1. Effects of theacrine on the astringency of EGCG by affecting salivary protein - EGCG interactions through different molecular mechanisms.
Xie J; Shi Y; Luo W; Fang W; Luo L; Zeng L
Food Chem X; 2024 Jun; 22():101474. PubMed ID: 38817981
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the Mechanisms of EGCG-p53 Interactions through Molecular Dynamics Simulations.
Bahena Culhuac E; Bello M
ACS Omega; 2024 May; 9(18):20066-20085. PubMed ID: 38737068
[TBL] [Abstract][Full Text] [Related]
3. From byte to bench to bedside: molecular dynamics simulations and drug discovery.
Ahmed M; Maldonado AM; Durrant JD
BMC Biol; 2023 Dec; 21(1):299. PubMed ID: 38155355
[No Abstract] [Full Text] [Related]
4. Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens.
Alaseem AM
Saudi Pharm J; 2023 Oct; 31(10):101790. PubMed ID: 37818252
[TBL] [Abstract][Full Text] [Related]
5. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H; Guo M; Wei H; Chen Y
Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
[TBL] [Abstract][Full Text] [Related]
6. RING 3.0: fast generation of probabilistic residue interaction networks from structural ensembles.
Clementel D; Del Conte A; Monzon AM; Camagni GF; Minervini G; Piovesan D; Tosatto SCE
Nucleic Acids Res; 2022 Jul; 50(W1):W651-W656. PubMed ID: 35554554
[TBL] [Abstract][Full Text] [Related]
7. Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study.
Surti M; Patel M; Adnan M; Moin A; Ashraf SA; Siddiqui AJ; Snoussi M; Deshpande S; Reddy MN
RSC Adv; 2020 Oct; 10(62):37707-37720. PubMed ID: 35515150
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions.
Munisamy M; Mukherjee N; Thomas L; Pham AT; Shakeri A; Zhao Y; Kolesar J; Rao PPN; Rangnekar VM; Rao M
Am J Cancer Res; 2021; 11(12):5762-5781. PubMed ID: 35018225
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Binding of Intrinsically Disordered Proteins from Molecular Dynamics Simulation.
Baker CM; Best RB
Wiley Interdiscip Rev Comput Mol Sci; 2014; 4(3):182-198. PubMed ID: 34354764
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Study of Conformational Changes of Tankyrase 2 Binding Subsites upon Ligand Binding.
Hirano Y; Okimoto N; Fujita S; Taiji M
ACS Omega; 2021 Jul; 6(27):17609-17620. PubMed ID: 34278146
[TBL] [Abstract][Full Text] [Related]
11. Exploring ligand binding pathways on proteins using hypersound-accelerated molecular dynamics.
Araki M; Matsumoto S; Bekker GJ; Isaka Y; Sagae Y; Kamiya N; Okuno Y
Nat Commun; 2021 May; 12(1):2793. PubMed ID: 33990583
[TBL] [Abstract][Full Text] [Related]
12. A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
Ramos H; Soares MIL; Silva J; Raimundo L; Calheiros J; Gomes C; Reis F; Monteiro FA; Nunes C; Reis S; Bosco B; Piazza S; Domingues L; Chlapek P; Vlcek P; Fabian P; Rajado AT; Carvalho ATP; Veselska R; Inga A; Pinho E Melo TMVD; Saraiva L
Cell Rep; 2021 Apr; 35(2):108982. PubMed ID: 33852837
[TBL] [Abstract][Full Text] [Related]
13. EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction.
Zhao J; Blayney A; Liu X; Gandy L; Jin W; Yan L; Ha JH; Canning AJ; Connelly M; Yang C; Liu X; Xiao Y; Cosgrove MS; Solmaz SR; Zhang Y; Ban D; Chen J; Loh SN; Wang C
Nat Commun; 2021 Feb; 12(1):986. PubMed ID: 33579943
[TBL] [Abstract][Full Text] [Related]
14. EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway.
Luo KW; Zhu XH; Zhao T; Zhong J; Gao HC; Luo XL; Huang WR
Front Cell Dev Biol; 2020; 8():606123. PubMed ID: 33425912
[TBL] [Abstract][Full Text] [Related]
15. Characterization of partially ordered states in the intrinsically disordered N-terminal domain of p53 using millisecond molecular dynamics simulations.
Herrera-Nieto P; Pérez A; De Fabritiis G
Sci Rep; 2020 Jul; 10(1):12402. PubMed ID: 32709860
[TBL] [Abstract][Full Text] [Related]
16. Investigating Cryptic Binding Sites by Molecular Dynamics Simulations.
Kuzmanic A; Bowman GR; Juarez-Jimenez J; Michel J; Gervasio FL
Acc Chem Res; 2020 Mar; 53(3):654-661. PubMed ID: 32134250
[TBL] [Abstract][Full Text] [Related]
17. PubChem 2019 update: improved access to chemical data.
Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
[TBL] [Abstract][Full Text] [Related]
18. Binding mechanism of kinase inhibitors to EGFR and T790M, L858R and L858R/T790M mutants through structural and energetic analysis.
Bello M
Int J Biol Macromol; 2018 Oct; 118(Pt B):1948-1962. PubMed ID: 30017980
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
